Özlem Türeci
Founder at BIONTECH SE
Net worth: 84 M $ as of 2024-03-30
Profile
Özlem Türeci founded BioNTech SE and Ganymed Pharmaceuticals AG. Currently, she holds the position of Chairman for Ci3 Management UG, President at Association For Cancer Immunotherapy and Chief Medical Officer for BioNTech SE. In the past she occupied the position of Chief Executive & Medical Officer at Ganymed Pharmaceuticals AG. Dr. Türeci received an undergraduate degree from Universität des Saarlandes.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIONTECH SE
0.38% | 2023-12-30 | 913,247 ( 0.38% ) | 84 M $ | 2024-03-30 |
Özlem Türeci active positions
| Companies | Position | Start |
|---|---|---|
| BIONTECH SE | Founder | 2008-06-01 |
| Association For Cancer Immunotherapy | President | - |
| Ci3 Management UG | Chairman | - |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Corporate Officer/Principal | - |
Former positions of Özlem Türeci
| Companies | Position | End |
|---|---|---|
Ganymed Pharmaceuticals AG
 Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Chief Executive Officer | - |
Training of Özlem Türeci
| Universität des Saarlandes | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIONTECH SE | Health Technology |
| Private companies | 4 |
|---|---|
Ganymed Pharmaceuticals AG
Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Health Technology |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Health Services |
| Association For Cancer Immunotherapy | |
| Ci3 Management UG |
- Stock Market
- Insiders
- Özlem Türeci
